Form D · Other Technology

Rivermark Medical, Inc.

Milwaukee, WI · CIK 0001893745

Offering snapshot reported Oct 11, 2024 · SEC filing

Reported sold: $4.12M
Investors reported: 6
Minimum accepted: $0
First sale: Jul 20, 2023

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,149,999 → $4,122,998
Reported investors3 → 6

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 11, 2024	Amendment	$4,122,998	$1,972,999vs Jul 31, 2023	6	SEC filing
Oct 11, 2024	Initial	$30,041,096	No comparison	16	SEC filing
Jul 31, 2023	Initial	$2,149,999	No comparison	3	SEC filing
Nov 19, 2021	Initial	$1,750,001	No comparison	5	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-488374

Source: Form D, filed Oct 11, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Josh Baltzell	Director
Joseph Biller	Director
Scott Button	Director
Anand Doraiswamy	Director, Executive
Matthew Ercolani	Director
Adam Kadlec	Director, Executive
Christopher Kaster	Director
Carter Meyer	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

758 N Broadway, Suite 234
Milwaukee, WI, 53202